Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.
CITATION STYLE
Della Volpe-Waizel, M., Traber, G. L., Maloca, P., Zinkernagel, M., Schmidt-Erfurth, U., Rubin, G., … Scholl, H. P. N. (2020, March 1). New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group. Ophthalmic Research. S. Karger AG. https://doi.org/10.1159/000501887
Mendeley helps you to discover research relevant for your work.